01 6Banzel
02 3Inovelan
03 3Inovelan/Banzel
04 1Inovelon/Banzel
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 222
2019 Revenue in Millions : 231
Growth (%) : -4
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 209
2019 Revenue in Millions : 203
Growth (%) : 3
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 85
2020 Revenue in Millions : 213
Growth (%) : -57
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 85
2020 Revenue in Millions : 200
Growth (%) : -54
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 62
2021 Revenue in Millions : 85
Growth (%) : -28
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 62
2021 Revenue in Millions : 85
Growth (%) : -28
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 30
2022 Revenue in Millions : 62
Growth (%) : -46
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 21
2016 Revenue in Millions : 18
Growth (%) : 16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 159
2016 Revenue in Millions : 127
Growth (%) : 26
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 22
2017 Revenue in Millions : 20
Growth (%) : 9%
LOOKING FOR A SUPPLIER?